These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32116433)

  • 1. Isolation and Immunological Detection of
    Ejeh FE; Undiandeye A; Okon K; Kazeem HM; Kudi AC
    Ethiop J Health Sci; 2020 Jan; 30(1):55-64. PubMed ID: 32116433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.
    Ejeh FE; Undiandeye A; Okon K; Moshood KH
    Pan Afr Med J; 2021; 38():203. PubMed ID: 33995809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pulmonary tuberculosis case detection improvement with the deployment of XpertMTB/Rif in the tuberculosis control program of cross River State, Nigeria.
    Ochang EA; Emanghe UE; Ewa A; Otu A; Offor JB; Odo M; Etokidem A; Afirima B; Owuna OE; Obeten SM; Meremikwu MM
    Int J Mycobacteriol; 2017; 6(1):94-96. PubMed ID: 28317812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
    E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
    Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontuberculous mycobacterial species and
    Mertaniasih NM; Kusumaningrum D; Koendhori EB; ; Kusmiati T; Dewi DN
    Int J Mycobacteriol; 2017; 6(1):9-13. PubMed ID: 28317798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria.
    Adejumo OA; Olusola-Faleye B; Adepoju V; Bowale A; Adesola S; Falana A; Owuna H; Otemuyiwa K; Oladega S; Adegboye O
    Afr Health Sci; 2018 Sep; 18(3):472-478. PubMed ID: 30602977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of rifampicin resistance by GeneXpert
    Rahman H; Khan SU; Khan MA; Qasim M; Jabbar A; Noor S; Khan Z; Khan TA; Hussain M; Muhammad N; Ali N
    J Glob Antimicrob Resist; 2017 Jun; 9():118-120. PubMed ID: 28501582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the G4 Xpert
    Dharan NJ; Blakemore R; Sloutsky A; Kaur D; Alexander RC; Ghajar M; Musser KA; Escuyer VE; Rowlinson MC; Crowe S; Laniado-Laborin R; Valli E; Nabeta P; Johnson P; Alland D
    BMC Infect Dis; 2016 Dec; 16(1):764. PubMed ID: 27993132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-emitting diode fluorescent microscopy and Xpert MTB/RIF® assay for diagnosis of pulmonary tuberculosis among patients attending Ambo hospital, west-central Ethiopia.
    Gelalcha AG; Kebede A; Mamo H
    BMC Infect Dis; 2017 Sep; 17(1):613. PubMed ID: 28893193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria.
    Aliyu G; El-Kamary SS; Abimiku A; Brown C; Tracy K; Hungerford L; Blattner W
    PLoS One; 2013; 8(5):e63170. PubMed ID: 23671669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV co-infection with tuberculous and non-tuberculous mycobacteria in western Kenya: challenges in the diagnosis and management.
    Nyamogoba HD; Mbuthia G; Mining S; Kikuvi G; Biegon R; Mpoke S; Menya D; Waiyaki PG
    Afr Health Sci; 2012 Sep; 12(3):305-11. PubMed ID: 23382744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
    Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria.
    Ugwu KO; Onah IS; Mbah GC; Ezeonu IM
    J Infect Dev Ctries; 2020 Sep; 14(9):1011-1018. PubMed ID: 33031090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GeneXpert
    Christopher PM; ; Widysanto A
    Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.